<?xml version="1.0" encoding="UTF-8"?>
<ref id="B55">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Joshi</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Joshi</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Sharma</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Mathpal</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Pundir</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Bhatt</surname>
    <given-names>V.</given-names>
   </name>
   <etal/>
  </person-group> (
  <year>2020</year>). 
  <article-title>In silico screening of natural compounds against COVID-19 by targeting Mpro and ACE2 using molecular docking</article-title>. 
  <source>Eur. Rev. Med. Pharmacol. Sci.</source>
  <volume>24</volume> (
  <issue>8</issue>), 
  <fpage>4529</fpage>â€“
  <lpage>4536</lpage>. 
  <pub-id pub-id-type="doi">10.26355/eurrev_202004_21036</pub-id>
  <pub-id pub-id-type="pmid">32373991</pub-id>
 </mixed-citation>
</ref>
